ASCO 2020：11项中国研究入选口头年度报告，17项Poster年度报告

受全球一新冠疫情冲击，原定于5年底29日~6年底2日在芝加哥举行的美国诊疗常务理事（ASCO）年会今年将首次以线上表现形式举办地，这是在此之前最大规模的线上盛会。今日，联席会议的简介题目公布，共有103个sessions，中所国共有有11项科学研究入选口头报告，17项入选Poster

Pyrotinib or lapatinib plus capecitabine for HER2+ metastatic breast cancer (PHOEBE): A randomized phase III trial.Session: Breast Cancer—MetastaticAuthor(s): Binghe Xu, Min Yan, Fei Ma, Xi-Chun Hu, Ji Feng Feng, Quchang Ouyang, Zhongsheng Tong, Huiping Li, Qingyuan Zhang, Tao Sun, Xian Wang, Yongmei Yin, Ying Cheng, Wei Li, Xiaoyu Zhu, Chunxia Chen, Jianjun ZouAbstract: 1003

吡咯替尼或罗德里格斯替尼加卡培他滨可用HER2+前列腺癌乳腺胃癌（PHOEBE）：一项III期随机飞行测试。

三场：前列腺癌乳腺胃癌

所写：北京协和医学院疗养院徐兵河名誉教授、马飞名誉教授，浙江大学附属疗养院胡夕春名誉教授等

简介号：1003

Phase III trial of metronomic capecitabine maintenance after standard treatment in operable triple-negative breast cancer (SYSUCC-001).

Session: Breast Cancer—Local/Regional/Adjuvant

Author(s): XI Wang, Shu-Sen Wang, Heng Huang, Li Cai, Rou-Jun Peng, Li Zhao, Ying Lin, Jian Zeng, Le-Hong Zhang, Yong-Li Ke, Xian-Ming Wang, Xin-Mei Liu, Qian-Jun Chen, An-Qin Zhang, Dan-Mei Pang, Fei Xu, Jia J. Huang, Yanxia Shi, Jun Tang, Zhongyu Yuan

Abstract: 507

可手术三阴性乳腺胃癌新标准疗程后卡培他滨维持节拍化疗的III期飞行测试（SYSUCC-001）。

三场：乳腺胃癌—大面积/区域/主要用途疗程

所写：中所山大学防治中所心王树森名誉教授等

简介号：507

Utilizing phenotypic characteristics of metastatic brain tumors to predict the probability of circulating tumor DNA detection from cerebrospinal fluid.Session: New Tools to Combat Old FoesAuthor(s): Meichen Li, Delan Li, Xue Hou, Xiangheng Zhang, Na Wang, Jianzhong Liang, Jing Chen, Kaicheng Wang, Fufeng Wang, Yedan Chen, Xian Zhang, Hua Bao, Xue Wu, Xiaonan Wang, Yang Shao, Likun ChenAbstract: 2507

能用前列腺癌脑的表型外观上来预测脑脊液中所气化DNA检测的概率: 一新工具对抗老对手

三场：一新工具解决老缺陷

所写：李美芹 李德兰等

简介号: 2507

Donafenib versus sorafenib as first-line therapy in advanced hepatocellular carcinoma: An open-label, randomized, multicenter phase II/III trial.

Session: Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Author(s): Feng Bi, Shukui Qin, Shanzhi Gu, Yuxian Bai, Zhendong Chen, Zishu Wang, Jieer Ying, Yinying Lu, Zhiqiang Meng, Hongming Pan, Ping Yang, Helong Zhang, Xi Chen, Aibing Xu, Xiufeng Liu, Qiu Meng, Liqing Wu, Feng Chen

Abstract: 4506

罗萨非尼对比索拉非尼作为末期肺蛋白胃癌的一线疗程：一项开放附加、随机、多中所心II/III期飞行测试。

三场：肺肠道胃癌—肺输尿管、发挥作用和肺胆

所写：湖南大学亚东疗养院毕锋名誉教授、中所国人民解放军八一疗养院秦叔逵名誉教授等

简介号：4506

Apatinib as second-line therapy in Chinese patients with advanced hepatocellular carcinoma: A randomized, placebo-controlled, double-blind, phase III study.

Session: Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Author(s): Qiu Li, Shukui Qin, Shanzhi Gu, Xiaoming Chen, Lizhu Lin, Zishu Wang, Aibing Xu, Xi Chen, Cuncai Zhou, Zhenggang Ren, Lin Yang, Li Xu, Yuxian Bai, Lei Chen, Jun Li, Hongming Pan, Bangwei Cao, Weijia Fang, Ping Yan, Chunlei Jin

Abstract: 4507

中所国末期肺胃癌病患者阿帕替尼中卫疗程：一项随机、安慰剂相比较、安慰剂III期科学研究

三场：肺肠道胃癌—肺输尿管、发挥作用和肺胆

所写：中所国人民解放军八一疗养院秦叔逵名誉教授、湖南大学亚东疗养院李秋名誉教授等

简介号：4507

A randomized phase III trial of secondary cytoreductive surgery in later recurrent ovarian cancer: SOC1/SGOG-OV2.

Session: Gynecologic Cancer

Author(s): Rongyu Zang, Jianqing Zhu, Tingyan Shi, Jihong Liu, Dongsheng Tu, Sheng Yin, Rong Jiang, Ping Zhang, Huixun Jia, Yuting Luan, Yuqin Zhang, Xiaojun Chen, Xiao Huang, Wenjuan Tian, Wen Gao, Yanling Feng, Huijuan Yang, Xi Cheng, Yulang Cai

Abstract: 6001

末期中风性卵巢胃癌二次蛋白减灭术的一项随机III期飞行测试：SOC1 / SGOG-OV2。

研讨：内科胃前列腺癌

所写：浙江大学附属中所山疗养院臧荣余名誉教授等

简介：6001

Sequential chemoradiation versus radiation alone or concurrent chemoradiation in adjuvant treatment after radical hysterectomy for stage IB1-IIA2 cervical cancer (STARS Study): A randomized, controlled, open-label, phase III trial.

Session: Gynecologic Cancer

Author(s): He Huang, Yanling Feng, Ting Wan, Yanna Zhang, Xinping Cao, Yongwen Huang, Ying Xiong, Xin Huang, Min Zheng, Yanfang Li, Jundong Li, Guandi Chen, Hu Li, Yile Chen, Liguo Ma, Hongying Yang, Li Li, Shuzhong Yao, Qing Liu, Jihong Liu

Abstract: 6007

IB1-IIA2期宫颈胃癌根治性子宫切除术后主要用途疗程中所的序贯放化疗对比单独放疗或联动放化疗（STARS科学研究）：一项随机、相比较、开放附加的III期飞行测试。

联席会议：内科胃前列腺癌

所写：中所山大学防治中所心马尔季尼夫卡名誉教授、刘继红名誉教授等

简介号：6007

CTONG1104: Adjuvant gefitinib versus chemotherapy for resected N1-N2 NSCLC with EGFR mutation—Final overall survival ysis of the randomized phase III trial 1 ysis of the randomized phase III trial.

Session: Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers

Author(s): Yi-Long Wu, Wenzhao Zhong, Qun Wang, Weimin Mao, Song-Tao Xu, Lin Wu, Chun Chen, Ying Cheng, Lin Xu, Jun Wang, Xiao-Fei Li, Jian Li, Cheng Huang, Zhidong Liu, Shun Xu, Jin-Ji Yang, Hong-Hong Yan, Xue-Ning Yang, Si-yang Liu, Qing Zhou

Abstract: 9005

CTONG1104：主要用途吉非替尼对比化疗可用可切除的EGFR等位基因的N1-N2期NSCLC-随机III期诊疗飞行测试的最终总体适应环境分析方法。

研讨：肺胃癌—非小蛋白大面积-区域/小蛋白/其他面部

所写：江门市人民疗养院吴一龙名誉教授等

简介号：9005

First-line tyrosine kinase inhibitor with or without aggressive upfront local radiation therapy in patients with EGFRm oligometastatic non-small cell lung cancer: Interim results of a randomized phase III, open-label clinical trial (SINDAS) (NCT02893332).

Session: Lung Cancer—Non-Small Cell Metastatic

Author(s): Xiaoshan Wang, Ming Zeng

Abstract: 9508

EGFR等位基因寡转移非小蛋白肺胃癌病患者一线半胱氨酸丝氨酸抑制剂联合行动或不联合行动致力第一线大面积放疗：III期开放附加诊疗随机飞行测试（SINDAS）的中所期结果（NCT02893332）。

研讨：肺胃癌-非小蛋白转移

所写：四川省人民疗养院曾铭名誉教授等

简介：9508

Overall survival and biomarker ysis of a phase Ib combination study of toripalimab, a humanized IgG4 mAb against programmed death-1 (PD-1) with axitinib in patients with metastatic mucosal melanoma.

Session: Melanoma/Skin Cancers

Author(s): Xinan Sheng, Xieqiao Yan, Zhihong Chi, Lu Si, Chuanliang Cui, Bixia Tang, Siming Li, Lili Mao, BIN LIAN, Xuan Wang, Xue Bai, Li Zhou, Yan Kong, Jie Dai, Keith Flaherty, Jun Guo

Abstract: 10007

Toripalimab，一种针对举例来说被害-1（PD-1）的人源化IgG4单克隆抗体联合行动阿昔替尼可用前列腺癌黏膜黑色素瘤病患者的Ib期科学研究的总适应环境期和生命体标志物分析方法。

研讨：黑色素瘤/皮肤胃癌

所写：北京大学疗养院郭军、盛锡楠名誉教授等

简介：10007

Safety and efficacy results of GC027: The first-in-human, universal CAR-T cell therapy for relapsed/refractory T-cell acute lymphoblastic leukemia (r/r T-ALL).Session: Developmental Therapeutics—ImmunotherapyAuthor(s): Xinxin Wang, Shiqi Li, Lei Gao, Zhongtao Yuan, Kun Wu, Lin Liu, Le Luo, Yao Liu, Cheng Zhang, Jia Liu, Chunhui Yang, Yu Li, Jiaping He, Xun Ye, Zhimin Li, Xu Tan, Jianning Ge, Wei Cao, Sanbin Wang, Xi ZhangAbstract: 3013Poster: 77 GC027的可靠性和结果：通用CAR-T蛋白首次生理飞行测试疗程中风/难治性T蛋白急性淋巴蛋白白血病（r/r T-ALL）的可靠性和。联席会议：开发中所的疗程技术-免疫疗程。所写：王林欣等简介：3013剧照：77 Sintilimab in patients with advanced esophageal squamous cell carcinoma refractory to previous chemotherapy: A randomized, open-label phase II trial (ORIENT-2).Session: Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and HepatobiliaryAuthor(s): Jianming Xu, Yi Li, Qingxia Fan, Yongqian Shu, Zhijun Wu, Tongjian Cui, Kangsheng Gu, Min Tao, Xiuwen Wang, Chengxu Cui, Nong Xu, Juxiang Xiao, Quanli Gao, Yunpeng Liu, Tao Zhang, Hui Zhou, Yan Wang, Linxinyu Xu, Zhuo Ma, Yanqi WangAbstract: 4511Poster: 119 信迪利抗肿瘤在末期输尿管鳞状蛋白胃癌病患者中所的应用于：一项随机的开放附加II期飞行测试（ORIENT-2）。联席会议：肺肠道胃癌-肺输尿管胃癌、发挥作用胃癌和肺胆道胃癌所写：徐建明名誉教授等简介：4511剧照：119 Eradication of medulloblastoma by NKG2D-specific CAR T-cells.Session: Central Nervous System TumorsAuthor(s): Hong-jiu Dai, Bin Sun, Dong Yang, Hui Xu, Jingjing Zhu, Jia Wei, Xudong ZhaoAbstract: 2522Poster: 13 NKG2D半胱氨酸CAR-T蛋白对髓母蛋白瘤的根除性疗程联席会议：中所枢神经系统所写：代红久、孙斌、杨东、徐晖、朱晶晶、魏佳、杨旭东简介：2522剧照。13 Envafolimab (KN035) in advanced tumors with mismatch-repair deficiency.Session: Developmental Therapeutics—ImmunotherapyAuthor(s): Lin Shen, Jian Li, Yanhong Deng, Weijie Zhang, Aiping Zhou, Weijian Guo, Jianwei Yang, Ying Yuan, Liangjun Zhu, Shukui Qin, Silong Xiang, Haolan Lu, John Gong, Ting Xu, Did LiuAbstract: 3021Poster: 85 Envafolimab（KN035）在末期错配修复缺陷病患者中所的应用于联席会议：开发中所的疗程学-免疫疗程所写：沈琳名誉教授等简介：3021剧照。85 First-in-human clinical trial of the autologous CD7-CART for relapsed/refractory ACUTE lymphoblastic leukemia/lymphoma.Session: Developmental Therapeutics—ImmunotherapyAuthor(s): Mingzhi Zhang, Lin Yang, Xiaorui Fu, Lei Zhang, Huimin Meng, Ling Li, Xin Li, Xinhua Wang, Zhenchang Sun, Hui Yu, Zhaoming Li, Feifei Nan, Yu Chang, Zhiyuan Zhou, Jiaqin Yan, Jiwei Li, Min Wang, Fengtao You, Yu-Sheng Chen, Bozhen ZhangAbstract: 3026Poster: 90 骨髓CD7-CART疗程中风/难治性ACUTE淋巴蛋白白血病/遗传病的首例生理诊疗飞行测试联席会议: 开发性疗程学-免疫疗程所写简介：张明志，杨林等简介：3026剧照: 90 A phase Ib study of simmitecan (LP) single-agent and in combination with 5-fluorouracil/leucovorin (5-FU/LV) or thalidomide (T) in patients with advanced solid tumor.Session: Developmental Therapeutics—Molecularly Targeted Agents and Tumor BiologyAuthor(s): Jifang Gong, Ting Deng, Jie Li, Ming Lu, Jian Li, Yi Ba, Qiuqiong Yu, Lin ShenAbstract: 3523Poster: 253 雷利替康（LP）单药和5-氟尿嘧啶/白藜芦醇（5-FU/LV）或沙利度胺（T）联合行动应可用末期实体瘤病患者的Ib期科学研究联席会议：发展性疗程学；还有分子靶向抗生素和生命体学所写：龚继芳，沈琳名誉教授等简介：3523剧照：253 A phase II study of rh-endostatin combined with paclitaxel and nedaplatin in treating patients with recurrent or metastatic esophageal squamous cell carcinoma (ESCC).Session: Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and HepatobiliaryAuthor(s): Zhiqiang Wang, Yu-Hong Li, De-Shen Wang, Fenghua Wang, Chao Ren, Qiong TanAbstract: 4522Poster: 130 Rh-endostatin联合行动糖类和nedaplatin疗程中风性或前列腺癌输尿管鳞状蛋白胃癌（ESCC）病患者的II期科学研究。联席会议：肺肠道胃癌-肺输尿管、发挥作用和肺胆道胃癌的科学研究所写：王志强于，李玉红，王德申，王凤华，任超，谭琼 王志强于、李玉红、王德深、王凤华、任超、谭琼简介：4522剧照：130 HX008, an anti-PD1 antibody, plus irinotecan as second-line treatment for advanced gastric adenocarcinoma: A phase II clinical trial.Session: Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and HepatobiliaryAuthor(s): Yan Song, Ning Li, Lan Mu, Shu Zhang, Qingxia Fan, Xinjun Liang, Xianli Yin, Zhixiang Zhuang, Yunpeng Liu, Jingdong Zhang, Xiaoge Kou, Haijun Zhong, Jing HuangAbstract: 4524Poster: 132 HX008, an anti-PD1 antibody, plus irinotecan as second-line treatment for advanced gastric adenocarcinoma: A phase II clinical trial.联席会议：肺肠道胃癌-肺输尿管胃癌、发挥作用胃癌和肺胆管胃癌的中卫疗程所写：宋艳等简介：4524剧照：132 A urine exosomal circRNA classifier for detection of high-grade prostate cancer at initial biopsy: A multicenter, retrospective study.Session: Genitourinary Cancer—Prostate, Testicular, and PenileAuthor(s): Liaoyuan Li, Wen Tao, Yadi He, Tao He, Qing Li, Zhenquan Wu, Weiming Deng, Lingxiao ZhangAbstract: 5522Poster: 103 一种分泌物外体环状RNA分类器可用初始活检时检测高等级胃癌的分泌物外体环状RNA分类器：一项多中所心的回顾性科学研究联席会议：泌尿上皮细胞胃前列腺癌；还有-胃癌、睾丸胃癌和胃癌所写简介：Liaoyuan Li等简介：5522剧照。103 Adjuvant chemotherapy after concurrent chemoradiation therapy for locally advanced cervical cancer.Session: Gynecologic CancerAuthor(s): Lingna Kou, Tao Zhang, Siyun Peng, Yifei Wang, Mingyang Yuan, Minmin LiAbstract: 6031Poster: 202 大面积末期宫颈胃癌并发化疗后的主要用途化疗联席会议: 内科胃前列腺癌所写简介： 李珉珉等简介：6031剧照：202 Association between calcitonin and efficacy of anlotinib in medullary thyroid carcinoma: An ysis based on the ALTER01031 trial.Session: Head and Neck CancerAuthor(s): Ming Gao, Yihebali Chi, Pingzhang Tang, Zhengang Xu, Xiangqian Zheng, Dapeng Li, Xiaohong Chen, Minghua Ge, Yuan Zhang, Zhuming Guo, Jun Wang, Jie Chen, Jiewu Zhang, Ying Cheng, Zhendong Li, Hui Liu, Jianwu Qin, Jingqiang Zhu, Ruochuan ChengAbstract: 6526Poster: 187 降钙素与安罗替尼疗程甲状腺髓性胃癌的相关性：基于ALTER01031飞行测试的分析方法。会福州话：黑纹所写：天津市疗养院得意名誉教授简介：6526剧照。187 Influence of Eastern Cooperative Oncology Group performance status (ECOG PS), tumor size and age on patient outcomes after anlotinib treatment: A subgroup ysis based on ALTER01031 trial for medullary thyroid carcinoma (MTC).Session: Head and Neck CancerAuthor(s): Ming Gao, Yihebali Chi, Xiangqian Zheng, Dapeng Li, Pingzhang Tang, Zhengang Xu, Xiaohong Chen, Minghua Ge, Yuan Zhang, Zhuming Guo, Jun Wang, Jie Chen, Jiewu Zhang, Ying Cheng, Zhendong Li, Hui Liu, Jianwu Qin, Jingqiang Zhu, Ruochuan ChengAbstract: 6527Poster: 188 ECOG PS、大小和年龄对安洛替尼疗程后病患者第一集的冲击: ALTER01031的亚组分析方法联席会议：黑纹所写：天津市疗养院得意名誉教授简介：6527剧照。188 Circulating tumor DNA (ctDNA) ysis predicts recurrence following surgery in patients with stage I-IIIA non-small-cell lung cancer (NSCLC): Results of GASTO1035 and GASTO1018.Session: Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic CancersAuthor(s): Si-Yu Wang, Ning Li, Wei Ou, Chao Cheng, Peng-Peng Kuang, Hui-Qi WuAbstract: 9023Poster: 216 ctDNA分析方法预测I-IIIA期非小蛋白肺胃癌（NSCLC）病患者术后中风: GASTO1035和GASTO1018的结果联席会议：肺胃癌-非小蛋白大面积-区域性/小蛋白/小蛋白/其他胸科胃前列腺癌所写：Si-Yu Wang等简介：9023剧照：216 Exon-16-skipping ERBB2 (ERBB2ΔEx16) as a novel resistance mechanism against EGFR tyrosine kinase inhibitors in non-small cell lung cancer (NSCLC).Session: Lung Cancer—Non-Small Cell MetastaticAuthor(s): Xin Zhao, Linling Jin, Man Yu, Qiuxiang Ou, Hua Bao, Xue Wu, Yang Shao, Min FanAbstract: 9528Poster: 294 ERBB2ΔEx16作为非小蛋白肺胃癌（NSCLC）中所EGFR半胱氨酸丝氨酸抑制剂的一新型病毒性组态联席会议:肺胃癌-非小蛋白前列腺癌肺胃癌所写简介：杨昕，金玲玲，满宇，欧青楼，双带，薛武，杨少，范敏 杨昕、金玲玲、满宇、欧青楼、双带、薛武、杨绍、范敏简介：9528剧照：294 Surrogate endpoints for overall survival in anti-programmed death-1 and anti-programmed death ligand 1 trials of advanced melanoma.Session: Melanoma/Skin CancersAuthor(s): Run-Cong Nie, Shu-Qiang Yuan, Yuanfang Li, Yingbo Chen, Zhiwei ZhouAbstract: 10030Poster: 379 PD-1/PD-L1飞行测试中所末期黑色素瘤总适应环境的替代终点联席会议：黑色素瘤/皮肤胃癌所写：聂润聪，袁书强于，李元芳，陈英波，周志伟 聂润聪、袁书强于、李元芳、陈英波、周志伟简介：10030剧照：379 A phase II study of anlotinib in treating patients with relapsed or metastatic primary malignant bone tumor.Session: SarcomaAuthor(s): Lina Tang, Xiaohui Niu, Zhen Wang, Qiqing Cai, Chongqi Tu, Zhengfu Fan, Yang YaoAbstract: 11525Poster: 413 安罗替尼疗程中风或前列腺癌原发性恶性骨病患者的II期科学研究联席会议： 畸形所写：唐丽娜，牛晓辉，许世友，蔡启清，涂崇奇，范正福，杨瑶 唐丽娜、牛晓辉、王振、蔡启庆、涂崇奇、范正福、杨瑶简介：11525剧照。413 Preliminary evaluate the safety and efficacy of anlotinib in advanced sarcoma patients in multi-line therapy.Session: SarcomaAuthor(s): Yao Weitao, Jiaqiang Wang, Peng Zhang, Xin Wang, Xinhui Du, Zhichao Tian, Xiaoying NiuAbstract: 11526Poster: 414 进一步评论者安罗替尼在末期畸形病患者多线疗程中所的可靠性和。联席会议：畸形所写：姚伟涛，王家强于，张鹏，王林，杜一新辉，田志浩，牛晓颖 姚伟涛、王家强于、张鹏、王鑫、杜鑫辉、田志超、牛晓英简介：11526剧照：414